Cannabichromene is a cannabinoid CB2 receptor agonist
M. P. Udoh, M. J. Santiago, S. Devenish, I. S. McGregor, M. Connor
This study identifies cannabichromene (CBC) as a selective CB2 receptor agonist with higher efficacy than THC in hyperpolarizing AtT20 cells.
bioRxiv · Nov 27, 2018Pharmacology & Toxicology